General Motors posted strong financial results for its first quarter Tuesday, but says it will reassess its expectations for ...

Equity amounted to ISK 42,421 million, and the equity ratio was 36.8% at the end of Q1 2025, compared to 37.9% at year-end ...

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

Inc.'s Q1 2025 earnings insights, including $2.1B revenue, strong Energy Equipment performance, and macroeconomic headwinds.

Net interest margin increased from 3.64% in Q4 2024 to 3.73% in Q1 2025. The efficiency ratio improved from 51.82% to 52.83%. Analysts' questions in Q1 2025 were more focused on managing macroeconomic ...

Live Updates Live Coverage Updates appear automatically as they are published. SPY Market Movers 10:41 am by Gerelyn Terzo ...

Q1 2025 Management View CEO Herve Hoppenot highlighted strong financial performance in Q1 2025, with total revenues reaching ...

Q1 2025 Management View CEO Sujal Patel highlighted progress in advancing Nautilus' proteome analysis platform, focusing on ...